Biotech Stocks See Bullish Options Flow

JC Parets
June 21, 2022

The largest insider transaction on today’s list comes in a Form 4 filing from Allied Physicians of California.

The firm reported a purchase of roughly $9.2 million in Apollo Medical Holdings $AMEH. It now owns about 11 million shares for a total ownership interest of 19%.

The CEO and president of Vacasa $VCSA revealed a purchase of 500,000 shares, equivalent to $1,385,600 worth of stock.

The only 13G on our list was filed by Deep Track Capital, revealing an ownership stake of 5.60% in the mid-cap biotech company Global Blood Therapeutics $GBT.

Here’s The Hot List, with data through June 17, 2022:

In another Form 4, the chairman and CEO of Shift4 Payments $FOUR disclosed a purchase of approximately $876,204 worth of his own stock.

There was also insider activity in OPKO Health $OPK and New Mountain Finance Corp $NMFC, as both CEOs reported small purchases.

In the options market, there was bullish flow in three biotech companies, Mind Medicine $MNMD, Liquidia Corp $LQDA, and Exelixis $EXEL.

There was also bullish flow in the Chinese automaker XPeng $XPEV and the industrial conglomerate 3M Company $MMM.

Stay tuned. We'll be back Wednesday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under